Vitiligo is a multifactorial disease characterized by the loss of skin pigment, which results in achromic macules and patches. There are currently several medical treatments available, which aim to arrest progression and induce skin repigmentation. These treatments alone or combined have exhibited varying degrees of pigmentation, and the majority are safe and effective. All therapies for vitiligo are limited, and no known treatment can consistently produce repigmen-tation in all patients. Individualized treatment is appropriate according to the location, clinical presentation and the presence of disease activity. The present review summarizes the medical treatments available for vitiligo: Systemic and topic pharmacological therapies, physical and depigmentation treatments. Several treatments are still underway and have not yet been approved. However, due to the promising preliminary results, these are also mentioned in the present review.
CITATION STYLE
Kubelis‑López, D., Zapata‑Salazar, N., Said‑Fernández, S., Sánchez‑Domínguez, C., Salinas‑Santander, M., Martínez‑Rodríguez, H., … Ocampo‑candiani, J. (2021). Updates and new medical treatments for vitiligo (Review). Experimental and Therapeutic Medicine, 22(2). https://doi.org/10.3892/etm.2021.10229
Mendeley helps you to discover research relevant for your work.